Nonoperative management of primary hyperparathyroidism: the exception rather than the rule

References

• Chen H. Surgery for primary hyperparathyroidism: what is the best approach? Ann. Surg.236(5), 552–553 (2002).
   Google Scholar
• Bilezikian J, Potts JJ, Fuleihan G-H et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J. Clin. Endocrinol. Metab.87(12), 5353–5361 (2002).
   PubMedGoogle Scholar
• Caron N, Pasieka J. What symptom improvement can be expected after operation for primary hyperparathyroidism? World J. Surg.33(11), 2244–2255 (2009).
   Google Scholar
• Silverberg S, Bilezikian J, Bone H, Talpos G, Horwitz M, Stewart A. Therapeutic controversies in primary hyperparathyroidism. J. Clin. Endocrinol. Metab.84(7), 2275–2285 (1999).
   Google Scholar
• Toft A. Surgery for primary hyperparathyroidism – sooner rather than later. Lancet355(9214), 1478–1479 (2000).
   PubMed Web of Science ®Google Scholar
• NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann. Intern. Med.114(7), 593–597 (1991).
   PubMed Web of Science ®Google Scholar
• Chan A, Duh Q, Katz M, Siperstein A, Clark O. Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case–control study. Ann. Surg.222(3), 402–412 (1995).
   PubMed Web of Science ®Google Scholar
• Mihai R, Sadler G. Pasieka’s parathyroid symptoms scores correlate with SF-36 scores in patients undergoing surgery for primary hyperparathyroidism. World J. Surg.32(5), 807–814 (2008).
   Google Scholar
• Sywak M, Knowlton S, Pasieka J, Parsons L, Jones J. Do the National Institutes of Health consensus guidelines for parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism? Surgery132(6), 1013–1019 (2002).
   Google Scholar
• Ambrogini E, Cetani F, Cianferotti L et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J. Clin. Endocrinol. Metab.92(8), 3114–3121 (2007).
   PubMed Web of Science ®Google Scholar
• Rao D, Phillips E, Divine G, Talpos G. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J. Clin. Endocrinol. Metab.89(11), 5415–5422 (2004).
   PubMed Web of Science ®Google Scholar
• Talpos G, Bone HR, Kleerekoper M et al. Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery128(6), 1013–1020 (2000).
   Google Scholar
• Chen H, Zeiger M, Gordon T, Udelsman R. Parathyroidectomy in Maryland: effects of an endocrine center. Surgery120(6), 948–952 (1996).
   Google Scholar
• Chen H, Parkerson S, Udelsman R. Parathyroidectomy in the elderly: do the benefits outweigh the risks? World J. Surg.22(6), 531–535 (1998).
   Google Scholar
• Bilezikian J, Silverberg S, Shane E, Parisien M, Dempster D. Characterization and evaluation of asymptomatic primary hyperparathyroidism. J. Bone Miner. Res.6(Suppl. 2), S85–S89 (1991).
   PubMedGoogle Scholar
• Mitlak B, Daly M, Potts JJ, Schoenfeld D, Neer R. Asymptomatic primary hyperparathyroidism. J. Bone Miner. Res.6(Suppl. 2), S103–S110 (1991).
   PubMedGoogle Scholar
• Elvius M, Lagrelius A, Nygren A, Alveryd A, Christensson T, Nordenström J. Seventeen year follow-up study of bone mass in patients with mild asymptomatic hyperparathyroidism some of whom were operated on. Eur. J. Surg.161(12), 863–869 (1995).
   PubMedGoogle Scholar
• Rao D, Wilson R, Kleerekoper M, Parfitt A. Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J. Clin. Endocrinol. Metab.67(6), 1294–1298 (1988).
   PubMed Web of Science ®Google Scholar
• Larsson K, Lindh E, Lind L, Persson I, Ljunghall S. Increased fracture risk in hypercalcemia. Bone mineral content measured in hyperparathyroidism. Acta Orthop. Scand.60(3), 268–270 (1989).
   PubMed Web of Science ®Google Scholar
• Seeman E, Wahner H, Offord K, Kumar R, Johnson W, Riggs B. Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J. Clin. Invest.69(6), 1302–1309 (1982).
   PubMed Web of Science ®Google Scholar
• Khan A, Bilezikian J. Primary hyperparathyroidism: pathophysiology and impact on bone. CMAJ163(2), 184–187 (2000).
   Google Scholar
• Leppla D, Snyder W, Pak C. Sequential changes in bone density before and after parathyroidectomy in primary hyperparathyroidism. Invest. Radiol.17(6), 604–606 (1982).
   Google Scholar
• Martin P, Bergmann P, Gillet C et al. Partially reversible osteopenia after surgery for primary hyperparathyroidism. Arch. Intern. Med.146(4), 689–691 (1986).
   PubMedGoogle Scholar
• Martin P, Bergmann P, Gillet C, Fuss M, Corvilain J, Van Geertruyden J. Long-term irreversibility of bone loss after surgery for primary hyperparathyroidism. Arch. Intern. Med.150(7), 1495–1497 (1990).
   PubMedGoogle Scholar
• Bilezikian J, Khan A, Potts JJ. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop. J. Clin. Endocrinol. Metab.94(2), 335–339 (2009).
   PubMed Web of Science ®Google Scholar
• Jorde R, Sundsfjord J. Bone mineral density and blood pressure in patients with asymptomatic hyperparathyroidism. The Tromsø Study. J. Intern. Med.247(3), 325–330 (2000).
   Google Scholar
• Hagström E, Lundgren E, Mallmin H, Rastad J, Hellman P. Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism. J. Intern. Med.259(2), 191–198 (2006).
   PubMed Web of Science ®Google Scholar
• Szulc P, Munoz F, Marchand F, Chapuy M, Delmas P. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study. Calcif. Tissue Int.73(6), 520–530 (2003).
   Google Scholar
• Garnero P, Munoz F, Sornay-Rendu E, Delmas P. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study. Bone40(3), 716–722 (2007).
   PubMed Web of Science ®Google Scholar
• Ward K, Klesges R. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif. Tissue Int.68(5), 259–270 (2001).
   PubMed Web of Science ®Google Scholar
• Brot C, Jorgensen N, Sorensen O. The influence of smoking on vitamin D status and calcium metabolism. Eur. J. Clin. Nutr.53(12), 920–926 (1999).
   PubMed Web of Science ®Google Scholar
• Sneve M, Emaus N, Joakimsen R, Jorde R. The association between serum parathyroid hormone and bone mineral density, and the impact of smoking: the Tromso Study. Eur. J. Endocrinol.158(3), 401–409 (2008).
   Google Scholar
• Walker M, Silverberg S. Parathyroidectomy in asymptomatic primary hyperparathyroidism: improves “bones” but not “psychic moans”. J. Clin. Endocrinol. Metab.92(5), 1613–1615 (2007).
   PubMed Web of Science ®Google Scholar
• Silverberg S, Gartenberg F, Jacobs T et al. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J. Clin. Endocrinol. Metab.80(3), 729–734 (1995).
   PubMed Web of Science ®Google Scholar
• Silverberg S, Shane E, Jacobs T, Siris E, Bilezikian J. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N. Engl. J. Med.341(17), 1249–1255 (1999).
   PubMed Web of Science ®Google Scholar
• Kaplan R, Snyder W, Stewart A, Pak C. Metabolic effects of parathyroidectomy in asymptomatic primary hyperparathyroidism. J. Clin. Endocrinol. Metab.42(3), 415–426 (1976).
   PubMed Web of Science ®Google Scholar
• Bollerslev J, Jansson S, Mollerup C et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J. Clin. Endocrinol. Metab.92(5), 1687–1692 (2007).
   PubMed Web of Science ®Google Scholar
• Nomura R, Sugimoto T, Tsukamoto T et al. Marked and sustained increase in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism; a six-year longitudinal study with or without parathyroidectomy in a Japanese population. Clin. Endocrinol. (Oxf.)60(3), 335–342 (2004).
   Google Scholar
• Christiansen P, Steiniche T, Brixen K et al. Primary hyperparathyroidism: short-term changes in bone remodeling and bone mineral density following parathyroidectomy. Bone25(2), 237–244 (1999).
   PubMedGoogle Scholar
• Christiansen P, Steiniche T, Brixen K et al. Primary hyperparathyroidism: effect of parathyroidectomy on regional bone mineral density in Danish patients: a three-year follow-up study. Bone25(5), 589–595 (1999).
   PubMed Web of Science ®Google Scholar
• Rubin M, Bilezikian J, McMahon D et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J. Clin. Endocrinol. Metab.93(9), 3462–3470 (2008).
   PubMed Web of Science ®Google Scholar
• Vestergaard P, Mollerup C, Frøkjaer V, Christiansen P, Blichert-Toft M, Mosekilde L. Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ321(7261), 598–602 (2000).
   PubMedGoogle Scholar
• Vestergaard P, Mosekilde L. Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ327(7414), 530–534 (2003).
   PubMedGoogle Scholar
• Khosla S, Melton Lr, Wermers R, Crowson C, O’Fallon W, Riggs B. Primary hyperparathyroidism and the risk of fracture: a population-based study. J. Bone Miner. Res.14(10), 1700–1707 (1999).
   PubMed Web of Science ®Google Scholar
• Kenny A, MacGillivray D, Pilbeam C, Crombie H, Raisz L. Fracture incidence in postmenopausal women with primary hyperparathyroidism. Surgery118(1), 109–114 (1995).
   PubMed Web of Science ®Google Scholar
• Larsson K, Ljunghall S, Krusemo U, Naessén T, Lindh E, Persson I. The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years. J. Intern. Med.234(6), 585–593 (1993).
   PubMed Web of Science ®Google Scholar
• Melton Lr, Atkinson E, O’Fallon W, Heath HR. Risk of age-related fractures in patients with primary hyperparathyroidism. Arch. Intern. Med.152(11), 2269–2273 (1992).
   PubMedGoogle Scholar
• Vestergaard P, Mosekilde L. Parathyroid surgery is associated with a decreased risk of hip and upper arm fractures in primary hyperparathyroidism: a controlled cohort study. J. Intern. Med.255(1), 108–114 (2004).
   Google Scholar
• Mack L, Pasieka J. Asymptomatic primary hyperparathyroidism: a surgical perspective. Surg. Clin. North Am.84(3), 803–816 (2004).
   Google Scholar
• Prager G, Kalaschek A, Kaczirek K et al. Parathyroidectomy improves concentration and retentiveness in patients with primary hyperparathyroidism. Surgery132(6), 930–935 (2002).
   PubMedGoogle Scholar
• Coker L, Rorie K, Cantley L et al. Primary hyperparathyroidism, cognition, and health-related quality of life. Ann. Surg.242(5), 642–650 (2005).
   PubMed Web of Science ®Google Scholar
• Burney R, Jones K, Coon J, Blewitt D, Herm A. Assessment of patient outcomes after operation for primary hyperparathyroidism. Surgery120(6), 1013–1018 (1996).
   PubMed Web of Science ®Google Scholar
• Burney R, Jones K, Christy B, Thompson N. Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels. Surgery125(6), 608–614 (1999).
   Google Scholar
• Jones K, Burney R, Peterson M, Christy B. Measuring health-status improvement after surgery: experience with the SF-36. Semin. Nurse Manag.6(3), 139–143 (1998).
   Google Scholar
• Joborn C, Hetta J, Lind L, Rastad J, Akerström G, Ljunghall S. Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing mild hypercalcemia. Surgery105(1), 72–78 (1989).
   PubMed Web of Science ®Google Scholar
• Numann P, Torppa A, Blumetti A. Neuropsychologic deficits associated with primary hyperparathyroidism. Surgery96(6), 1119–1123 (1984).
   PubMed Web of Science ®Google Scholar
• Brown G, Preisman R, Kleerekoper M. Neurobehavioral symptoms in mild primary hyperparathyroidism: related to hypercalcemia but not improved by parathyroidectomy. Henry Ford Hosp. Med. J.35(4), 211–215 (1987).
   PubMedGoogle Scholar
• Goyal A, Chumber S, Tandon N, Lal R, Srivastava A, Gupta S. Neuropsychiatric manifestations in patients of primary hyperparathyroidism and outcome following surgery. Indian J. Med. Sci.55(12), 677–686 (2001).
   Google Scholar
• Cogan M, Covey C, Arieff A et al. Central nervous system manifestations of hyperparathyroidism. Am. J. Med.65(6), 963–970 (1978).
   PubMed Web of Science ®Google Scholar
• Chiang C, Andrewes D, Anderson D, Devere M, Schweitzer I, Zajac J. A controlled, prospective study of neuropsychological outcomes post parathyroidectomy in primary hyperparathyroid patients. Clin. Endocrinol. (Oxf.)62(1), 99–104 (2005).
   PubMed Web of Science ®Google Scholar
• Pasieka J, Parsons L. Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J. Surg.22(6), 513–518 (1998).
   PubMed Web of Science ®Google Scholar
• Pasieka J, Parsons L, Demeure M et al. Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J. Surg.26(8), 942–949 (2002).
   PubMed Web of Science ®Google Scholar
• Adler J, Sippel R, Schaefer S, Chen H. Surgery improves quality of life in patients with “mild” hyperparathyroidism. Am. J. Surg.197(3), 284–290 (2009).
   Google Scholar
• Sheldon D, Lee F, Neil N, Ryan JJ. Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch. Surg.137(9), 1022–1026 (2002).
   Google Scholar
• Silverberg S, Lewiecki E, Mosekilde L, Peacock M, Rubin M. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the Third International Workshop. J. Clin. Endocrinol. Metab.94(2), 351–365 (2009).
   PubMed Web of Science ®Google Scholar
• Perrier N, Coker L, Rorie K et al. Preliminary report: functional MRI of the brain may be the ideal tool for evaluating neuropsychologic and sleep complaints of patients with primary hyperparathyroidism. World J. Surg.30(5), 686–696 (2006).
   Google Scholar
• Hedbäck G, Tisell L, Bengtsson B, Hedman I, Oden A. Premature death in patients operated on for primary hyperparathyroidism. World J. Surg.14(6), 829–835 (1990).
   PubMed Web of Science ®Google Scholar
• Hedbäck G, Odén A. Increased risk of death from primary hyperparathyroidism – an update. Eur J. Clin. Invest.28(4), 271–276 (1998).
   PubMed Web of Science ®Google Scholar
• Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease – a review. Eur. Heart J.25(20), 1776–1787 (2004).
   PubMed Web of Science ®Google Scholar
• Querfeld U, Hoffmann M, Klaus G et al. Antagonistic effects of vitamin D and parathyroid hormone on lipoprotein lipase in cultured adipocytes. J. Am. Soc. Nephrol.10(10), 2158–2164 (1999).
   PubMed Web of Science ®Google Scholar
• Lafferty F. Primary hyperparathyroidism. Changing clinical spectrum, prevalence of hypertension, and discriminant analysis of laboratory tests. Arch. Intern. Med.141(13), 1761–1766 (1981).
   PubMed Web of Science ®Google Scholar
• Kovács L, Góth M, Szabolcs I, Dohán O, Ferencz A, Szilágyi G. The effect of surgical treatment on secondary hyperaldosteronism and relative hyperinsulinemia in primary hyperparathyroidism. Eur. J. Endocrinol.138(5), 543–547 (1998).
   Google Scholar
• Stefenelli T, Wikman-Coffelt J, Wu S, Parmley W. Calcium-dependent fluorescence transients during ventricular fibrillation. Am. Heart J.120(3), 590–597 (1990).
   Google Scholar
• Wald D. ECG manifestations of selected metabolic and endocrine disorders. Emerg. Med. Clin. North Am.24(1), 145–157 vii (2006).
   Google Scholar
• Vázquez-Díaz O, Castillo-Martínez L, Orea-Tejeda A et al. Reversible changes of electrocardiographic abnormalities after parathyroidectomy in patients with primary hyperparathyroidism. Cardiol. J.16(3), 241–245 (2009).
   PubMed Web of Science ®Google Scholar
• Näppi S, Saha H, Virtanen V et al. Left ventricular structure and function in primary hyperparathyroidism before and after parathyroidectomy. Cardiology93(4), 229–233 (2000).
   Google Scholar
• Marx S. Hyperparathyroid and hypoparathyroid disorders. N. Engl. J. Med.343(25), 1863–1875 (2000).
   PubMed Web of Science ®Google Scholar
• Schlüter K, Weber M, Piper H. Effects of PTH-rP(107–111) and PTH-rP(7–34) on adult cardiomyocytes. J. Mol. Cell. Cardiol.29(11), 3057–3065 (1997).
   PubMed Web of Science ®Google Scholar
• Hara M, Liu Y, Zhen L et al. Positive chronotropic actions of parathyroid hormone and parathyroid hormone-related peptide are associated with increases in the current, I(f), and the slope of the pacemaker potential. Circulation96(10), 3704–3709 (1997).
   PubMed Web of Science ®Google Scholar
• Smogorzewski M, Perna A, Borum P, Massry S. Fatty acid oxidation in the myocardium: effects of parathyroid hormone and CRF. Kidney Int.34(6), 797–803 (1988).
   Google Scholar
• Bogin E, Levi J, Harary I, Massry S. Effects of parathyroid hormone on oxidative phosphorylation of heart mitochondria. Miner. Electrolyte Metab.7(3), 151–156 (1982).
   PubMedGoogle Scholar
• Smogorzewski M, Zayed M, Zhang Y, Roe J, Massry S. Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes. Am. J. Physiol.264(6 Pt 2), H1998–H2006 (1993).
   PubMedGoogle Scholar
• Symons C, Fortune F, Greenbaum R, Dandona P. Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism – an association. Br. Heart J.54(5), 539–542 (1985).
   PubMedGoogle Scholar
• Längle F, Abela C, Koller-Strametz J et al. Primary hyperparathyroidism and the heart: cardiac abnormalities correlated to clinical and biochemical data. World J. Surg.18(4), 619–624 (1994).
   Google Scholar
• Stefenelli T, Abela C, Frank H et al. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J. Clin. Endocrinol. Metab.82(1), 106–112 (1997).
   PubMed Web of Science ®Google Scholar
• Dalberg K, Brodin L, Juhlin-Dannfelt A, Farnebo L. Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study. Eur. J. Surg.162(3), 171–176 (1996).
   PubMedGoogle Scholar
• Piovesan A, Molineri N, Casasso F et al. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin. Endocrinol. (Oxf.)50(3), 321–328 (1999).
   PubMed Web of Science ®Google Scholar
• Almqvist E, Bondeson A, Bondeson L, Nissborg A, Smedgård P, Svensson S. Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy. Surgery132(6), 1126–1132 (2002).
   PubMedGoogle Scholar
• Kosch M, Hausberg M, Vormbrock K et al. Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc. Res.47(4), 813–818 (2000).
   Google Scholar
• Smith J, Page M, John R et al. Augmentation of central arterial pressure in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab.85(10), 3515–3519 (2000).
   Google Scholar
• Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am. J. Med.95(2), 197–202 (1993).
   PubMedGoogle Scholar
• Ahlström T, Hagström E, Larsson A, Rudberg C, Lind L, Hellman P. Correlation between plasma calcium, parathyroid hormone and the metabolic syndrome in a community-based cohort of men and women. Clin. Endocrinol. (Oxf.) (2009).
   Google Scholar
• Hagström E, Lundgren E, Lithell H et al. Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin. Endocrinol. (Oxf.)56(2), 253–260 (2002).
   PubMedGoogle Scholar
• Hagström E, Lundgren E, Rastad J, Hellman P. Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. Eur. J. Endocrinol.155(1), 33–39 (2006).
   Google Scholar
• Nilsson I, Aberg J, Rastad J, Lind L. Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery126(6), 1049–1055 (1999).
   Google Scholar
• Nilsson I, Aberg J, Rastad J, Lind L. Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism-effects of parathyroidectomy. Surgery128(6), 895–902 (2000).
   Google Scholar
• Nilsson I, Aberg J, Rastad J, Lind L. Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism. Surgery137(6), 632–638 (2005).
   PubMed Web of Science ®Google Scholar
• Kautzky-Willer A, Pacini G, Niederle B, Schernthaner G, Prager R. Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery. Clin. Endocrinol. (Oxf.)37(2), 147–155 (1992).
   Google Scholar
• Richards M, Thompson N. Diabetes mellitus with hyperparathyroidism: another indication for parathyroidectomy? Surgery126(6), 1160–1166 (1999).
   Google Scholar
• Hedbäck G, Odén A, Tisell L. The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J. Surg.15(3), 399–405 (1991).
   PubMed Web of Science ®Google Scholar
• Söreide J, van Heerden J, Grant C, Yau Lo C, Schleck C, Ilstrup D. Survival after surgical treatment for primary hyperparathyroidism. Surgery122(6), 1117–1123 (1997).
   PubMed Web of Science ®Google Scholar
• Wermers R, Khosla S, Atkinson E et al. Survival after the diagnosis of hyperparathyroidism: a population-based study. Am. J. Med.104(2), 115–122 (1998).
   PubMed Web of Science ®Google Scholar
• Wermers R, Khosla S, Atkinson E et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease. J. Bone Miner. Res.21(1), 171–177 (2006).
   PubMed Web of Science ®Google Scholar
• Nilsson I, Yin L, Lundgren E, Rastad J, Ekbom A. Clinical presentation of primary hyperparathyroidism in Europe – nationwide cohort analysis on mortality from nonmalignant causes. J. Bone Miner. Res.17(Suppl. 2), N68–N74 (2002).
   Web of Science ®Google Scholar
• Patten B, Bilezikian J, Mallette L, Prince A, Engel W, Aurbach G. Neuromuscular disease in primary hyperparathyroidism. Ann. Intern. Med.80(2), 182–193 (1974).
   PubMed Web of Science ®Google Scholar
• Reppe S, Stilgren L, Abrahamsen B et al. Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism. Am. J. Physiol. Endocrinol. Metab.292(5), E1465–E1473 (2007).
   Google Scholar
• Turken S, Cafferty M, Silverberg S et al. Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism. Am. J. Med.87(5), 553–557 (1989).
   PubMed Web of Science ®Google Scholar
• Minisola S, Carnevale V, Romagnoli E et al. [Primary hyperparathyroidism: the recent findings]. Medicina (Firenze)10(3), 263–272 (1990).
   Google Scholar
• Hedman I, Grimby G, Tisell L. Improvement of muscle strength after treatment for hyperparathyroidism. Acta Chir. Scand.150(7), 521–524 (1984).
   PubMedGoogle Scholar
• Jansson S, Grimby G, Hagne I, Hedman I, Tisell L. Muscle structure and function before and after surgery for primary hyperparathyroidism. Eur. J. Surg.157(1), 13–16 (1991).
   PubMedGoogle Scholar
• Wersäll-Robertson E, Hamberger B, Ehrén H, Eriksson E, Granberg P. Increase in muscular strength following surgery for primary hyperparathyroidism. Acta Med. Scand.220(3), 233–235 (1986).
   PubMedGoogle Scholar
• Joborn C, Joborn H, Rastad J, Akerström G, Ljunghall S. Maximal isokinetic muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery. Br. J. Surg.75(1), 77–80 (1988).
   PubMed Web of Science ®Google Scholar
• Chou F, Sheen-Chen S, Leong C. Neuromuscular recovery after parathyroidectomy in primary hyperparathyroidism. Surgery117(1), 18–25 (1995).
   PubMed Web of Science ®Google Scholar
• Deutch S, Jensen M, Christiansen P, Hessov I. Muscular performance and fatigue in primary hyperparathyroidism. World J. Surg.24(1), 102–107 (2000).
   Google Scholar
• Edwards M, Rotramel A, Beyer T et al. Improvement in the health-related quality-of-life symptoms of hyperparathyroidism is durable on long-term follow-up. Surgery140(4), 655–663 (2006).
   Google Scholar